According to a new report on the size of the allergy drug market in the US, allergy sufferers could be spending $14.7 billion by 2015. That’s in the US alone.

Seems that if you are looking for a good investment, you might want to buy stock in companies that sell allergy remedies.

The market is being driven by the explosion in allergies in developed countries. Allergy now ranks as one of the most common chronic diseases in the population.

It’s not just over-the-counter (OTC) drugs that US consumers are looking for. They also want more alternative medicine to handle those allergic symptoms.

Source: PR Web